Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1910 1
1913 1
1943 2
1944 1
2001 1
2002 1
2003 3
2004 1
2005 6
2006 6
2008 1
2009 4
2010 9
2011 9
2012 13
2013 13
2014 6
2015 5
2016 5
2017 4
2018 2
2019 4
2020 4
2021 2
2022 6
2023 1
2024 5
2025 4

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

109 results

Results by year

Filters applied: . Clear all
Page 1
Relacorilant and nab-paclitaxel in patients with platinum-resistant ovarian cancer (ROSELLA): an open-label, randomised, controlled, phase 3 trial.
Olawaiye AB, Gladieff L, O'Malley DM, Kim JW, Garbaos G, Salutari V, Gilbert L, Mileshkin L, Devaux A, Hopp E, Lee YJ, Oaknin A, Scaranti M, Kim BG, Colombo N, McCollum ME, Diakos C, Clamp A, Leiser AL, Balázs B, Monk BJ, Scandurra G, McClung E, Kaczmarek E, Slomovitz B, De La Cueva H, de Carvalho Calabrich AF, Cassani C, You B, Van Gorp T, Churruca C, Caruso G, Nicum S, Bagaméri A, Artioli G, Bodnar L, Kang S, Vergote I, Kesner-Hays A, Pashova HI, Pai SG, Tudor IC, Jubb AM, Lorusso D. Olawaiye AB, et al. Among authors: jubb am. Lancet. 2025 Jun 21;405(10496):2205-2216. doi: 10.1016/S0140-6736(25)01040-2. Epub 2025 Jun 2. Lancet. 2025. PMID: 40473448 Clinical Trial.
Cyclin E1/CDK2 activation defines a key vulnerability to WEE1 kinase inhibition in gynecological cancers.
Kim D, Chung H, Liu W, Jeong K, Ozmen TY, Ozmen F, Rames MJ, Kim S, Guo X, Jameson N, de Jong PR, Yea S, Harford L, Li J, Mathews CA, Doroshow DB, Charles VJ, Kim D, Fischer K, Samatar AA, Jubb A, Bunker KD, Blackwell K, Simpkins F, Meric-Bernstam F, Mills GB, Harismendy O, Ma J, Lackner MR. Kim D, et al. Among authors: jubb a. NPJ Precis Oncol. 2025 Jan 4;9(1):3. doi: 10.1038/s41698-024-00787-4. NPJ Precis Oncol. 2025. PMID: 39755818 Free PMC article.
A Case of Dwarfism.
Jubb AA. Jubb AA. Br Med J. 1910 Dec 31;2(2609):2026. doi: 10.1136/bmj.2.2609.2026. Br Med J. 1910. PMID: 20765384 Free PMC article. No abstract available.
Genetic Variation and Stroke Recovery: The STRONG Study.
Cramer SC, Parodi L, Moslemi Z, Braun RG, Aldridge CM, Shahbaba B, Rosand J, Holman EA; STRONG Study Investigators. Cramer SC, et al. Stroke. 2024 Aug;55(8):2094-2102. doi: 10.1161/STROKEAHA.124.047643. Epub 2024 Jul 9. Stroke. 2024. PMID: 38979623 Free PMC article.
Methylation and colorectal cancer.
Jubb AM, Bell SM, Quirke P. Jubb AM, et al. J Pathol. 2001 Sep;195(1):111-34. doi: 10.1002/path.923. J Pathol. 2001. PMID: 11568897 Review.
EphB2 is a prognostic factor in colorectal cancer.
Jubb AM, Zhong F, Bheddah S, Grabsch HI, Frantz GD, Mueller W, Kavi V, Quirke P, Polakis P, Koeppen H. Jubb AM, et al. Clin Cancer Res. 2005 Jul 15;11(14):5181-7. doi: 10.1158/1078-0432.CCR-05-0143. Clin Cancer Res. 2005. PMID: 16033834
Advancing drug discovery using the power of the human genome.
Heilbron K, Mozaffari SV, Vacic V, Yue P, Wang W, Shi J, Jubb AM, Pitts SJ, Wang X. Heilbron K, et al. Among authors: jubb am. J Pathol. 2021 Jul;254(4):418-429. doi: 10.1002/path.5664. Epub 2021 Apr 9. J Pathol. 2021. PMID: 33748968 Free PMC article. Review.
109 results